CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denis, G. V.
Right arrow Articles by Faller, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, G. V.
Right arrow Articles by Faller, D. V.
Cell Growth & Differentiation Vol. 11, 417-424, August 2000
© 2000 American Association for Cancer Research

RING3 Kinase Transactivates Promoters of Cell Cycle Regulatory Genes through E2F1

Gerald V. Denis2, Cyrus Vaziri, Ning Guo and Douglas V. Faller

Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts 02118

RING3 is a novel, nuclear-localized, serine-threonine kinase that has elevated activity in human leukemias. RING3 transforms NIH/3T3 cells and is activated by mitogenic signals, all of which suggest that it may play a role in cell cycle-responsive transcription. We tested this hypothesis with transient transfection of RING3 into fibroblasts and assayed transactivation of the promoters of cyclin D1, cyclin A, cyclin E, and dihydrofolate reductase (dhfr) genes. RING3 transactivates these promoters in a manner dependent on ras signaling. A kinase-deficient point mutant of RING3 does not transactivate. Mutational analysis of the dhfr promoter reveals that transactivation also depends on the presence of a functional E2F binding site. Furthermore, ectopic expression of Rb protein, a negative regulator of E2F activity, suppresses the RING3-dependent transactivation of this promoter. Consistent with a potential role of E2F in RING3-dependent transcription, anti-RING3 immunoaffinity chromatography or recombinant RING3 protein affinity chromatography of nuclear extracts copurified a protein complex that contains E2F-1 and E2F-2. These data suggest that RING3 is a potentially important regulator of E2F-dependent cell cycle genes.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. H. Bui, X. Lin, D. H. Albert, L. Li, L. T. Lam, E. J. Faivre, S. E. Warder, X. Huang, D. Wilcox, C. K. Donawho, et al.
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
Cancer Res., June 1, 2017; 77(11): 2976 - 2989.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Andrieu, A. H. Tran, K. J. Strissel, and G. V. Denis
BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
Cancer Res., November 15, 2016; 76(22): 6555 - 6567.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
E. S. Klaus, N. H. Gonzalez, M. Bergmann, M. Bartkuhn, W. Weidner, S. Kliesch, and C. Rathke
Murine and Human Spermatids Are Characterized by Numerous, Newly Synthesized and Differentially Expressed Transcription Factors and Bromodomain-Containing Proteins
Biol Reprod, July 7, 2016; 95(1): 4 - 4.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Sun, H. C. Jha, and E. S. Robertson
Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis
J. Virol., October 15, 2015; 89(20): 10206 - 10218.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Garcia-Gutierrez, F. Juarez-Vicente, D. J. Wolgemuth, and M. Garcia-Dominguez
Pleiotrophin antagonizes Brd2 during neuronal differentiation
J. Cell Sci., June 1, 2014; 127(11): 2554 - 2564.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Liu, S. R. Walker, E. A. Nelson, R. Cerulli, M. Xiang, P. A. Toniolo, J. Qi, R. M. Stone, M. Wadleigh, J. E. Bradner, et al.
Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
Mol. Cancer Ther., May 1, 2014; 13(5): 1194 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. C. Belkina, W. P. Blanton, B. S. Nikolajczyk, and G. V. Denis
The double bromodomain protein Brd2 promotes B cell expansion and mitogenesis
J. Leukoc. Biol., March 1, 2014; 95(3): 451 - 460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Wienerroither, I. Rauch, F. Rosebrock, A. M. Jamieson, J. Bradner, M. Muhar, J. Zuber, M. Muller, and T. Decker
Regulation of NO Synthesis, Local Inflammation, and Innate Immunity to Pathogens by BET Family Proteins
Mol. Cell. Biol., February 1, 2014; 34(3): 415 - 427.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Hnilicova, S. Hozeifi, E. Stejskalova, E. Duskova, I. Poser, J. Humpolickova, M. Hof, and D. Stanek
The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing
Mol. Biol. Cell, November 15, 2013; 24(22): 3557 - 3568.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
J. D. Merker, K. M. Roskin, D. Ng, C. Pan, D. G. Fisk, J. J. King, R. Hoh, M. Stadler, L. M. Okumoto, P. Abidi, et al.
Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes
Haematologica, November 1, 2013; 98(11): 1689 - 1696.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Belkina, B. S. Nikolajczyk, and G. V. Denis
BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
J. Immunol., April 1, 2013; 190(7): 3670 - 3678.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Garcia-Gutierrez, M. Mundi, and M. Garcia-Dominguez
Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B
J. Cell Sci., August 1, 2012; 125(15): 3671 - 3680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Rahman, M. E. Sowa, M. Ottinger, J. A. Smith, Y. Shi, J. W. Harper, and P. M. Howley
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Mol. Cell. Biol., July 1, 2011; 31(13): 2641 - 2652.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ohta, T. Shiina, R. L. Lohr, K. Hosomichi, T. I. Pollin, E. J. Heist, S. Suzuki, H. Inoko, and M. F. Flajnik
Primordial Linkage of {beta}2-Microglobulin to the MHC
J. Immunol., March 15, 2011; 186(6): 3563 - 3571.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
C. A. Airoldi, F. D. Rovere, G. Falasca, G. Marino, M. Kooiker, M. M. Altamura, S. Citterio, and M. M. Kater
The Arabidopsis BET Bromodomain Factor GTE4 Is Involved in Maintenance of the Mitotic Cell Cycle during Plant Development
Plant Physiology, March 1, 2010; 152(3): 1320 - 1334.
[Abstract] [Full Text] [PDF]


Home page
Biochem. J.Home page
Brd2 disruption in mice causes severe obesity without Type 2 diabetes
Biochem. J., January 1, 2010; 425(1): 71 - 85.



Home page
J Biol ChemHome page
K. Mochizuki, A. Nishiyama, M. K. Jang, A. Dey, A. Ghosh, T. Tamura, H. Natsume, H. Yao, and K. Ozato
The Bromodomain Protein Brd4 Stimulates G1 Gene Transcription and Promotes Progression to S Phase
J. Biol. Chem., April 4, 2008; 283(14): 9040 - 9048.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S.-Y. Wu and C.-M. Chiang
The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation
J. Biol. Chem., May 4, 2007; 282(18): 13141 - 13145.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. E. Lenburg, A. Sinha, D. V. Faller, and G. V. Denis
Tumor-specific and Proliferation-specific Gene Expression Typifies Murine Transgenic B Cell Lymphomagenesis
J. Biol. Chem., February 16, 2007; 282(7): 4803 - 4811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day
Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer
Cancer Res., December 15, 2006; 66(24): 11897 - 11906.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Ottinger, T. Christalla, K. Nathan, M. M. Brinkmann, A. Viejo-Borbolla, and T. F. Schulz
Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G1 Cell Cycle Arrest
J. Virol., November 1, 2006; 80(21): 10772 - 10786.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S.-Y. Wu, A-Y. Lee, S. Y. Hou, J. K. Kemper, H. Erdjument-Bromage, P. Tempst, and C.-M. Chiang
Brd4 links chromatin targeting to HPV transcriptional silencing
Genes & Dev., September 1, 2006; 20(17): 2383 - 2396.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Viejo-Borbolla, M. Ottinger, E. Bruning, A. Burger, R. Konig, E. Kati, J. A. Sheldon, and T. F. Schulz
Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1
J. Virol., November 1, 2005; 79(21): 13618 - 13629.
[Abstract] [Full Text] [PDF]


Home page
Biochem. J.Home page
A. SINHA, D. V. FALLER, and G. V. DENIS
Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A
Biochem. J., April 1, 2005; 387(1): 257 - 269.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Farina, M. Hattori, J. Qin, Y. Nakatani, N. Minato, and K. Ozato
Bromodomain Protein Brd4 Binds to GTPase-Activating SPA-1, Modulating Its Activity and Subcellular Localization
Mol. Cell. Biol., October 15, 2004; 24(20): 9059 - 9069.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L.-Y. Wong, G. A. Matchett, and A. C. Wilson
Transcriptional Activation by the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Is Facilitated by an N-Terminal Chromatin-Binding Motif
J. Virol., September 15, 2004; 78(18): 10074 - 10085.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Spira, J. Beane, V. Shah, G. Liu, F. Schembri, X. Yang, J. Palma, and J. S. Brody
Effects of cigarette smoke on the human airway epithelial cell transcriptome
PNAS, July 6, 2004; 101(27): 10143 - 10148.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Taubert, C. Gorrini, S. R. Frank, T. Parisi, M. Fuchs, H.-M. Chan, D. M. Livingston, and B. Amati
E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1
Mol. Cell. Biol., May 15, 2004; 24(10): 4546 - 4556.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. J. Greenwald, J. R. Tumang, A. Sinha, N. Currier, R. D. Cardiff, T. L. Rothstein, D. V. Faller, and G. V. Denis
E{micro}-BRD2 transgenic mice develop B-cell lymphoma and leukemia
Blood, February 15, 2004; 103(4): 1475 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Canaple, T. Kakizawa, and V. Laudet
The Days and Nights of Cancer Cells
Cancer Res., November 15, 2003; 63(22): 7545 - 7552.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Dey, F. Chitsaz, A. Abbasi, T. Misteli, and K. Ozato
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
PNAS, July 22, 2003; 100(15): 8758 - 8763.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Viejo-Borbolla, E. Kati, J. A. Sheldon, K. Nathan, K. Mattsson, L. Szekely, and T. F. Schulz
A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin
J. Virol., June 15, 2003; 77(12): 7093 - 7100.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Maruyama, A. Farina, A. Dey, J. Cheong, V. P. Bermudez, T. Tamura, S. Sciortino, J. Shuman, J. Hurwitz, and K. Ozato
A Mammalian Bromodomain Protein, Brd4, Interacts with Replication Factor C and Inhibits Progression to S Phase
Mol. Cell. Biol., September 15, 2002; 22(18): 6509 - 6520.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Houzelstein, S. L. Bullock, D. E. Lynch, E. F. Grigorieva, V. A. Wilson, and R. S. P. Beddington
Growth and Early Postimplantation Defects in Mice Deficient for the Bromodomain-Containing Protein Brd4{dagger}
Mol. Cell. Biol., June 1, 2002; 22(11): 3794 - 3802.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Grundschober, F. Delaunay, A. Puhlhofer, G. Triqueneaux, V. Laudet, T. Bartfai, and P. Nef
Circadian Regulation of Diverse Gene Products Revealed by mRNA Expression Profiling of Synchronized Fibroblasts
J. Biol. Chem., December 14, 2001; 276(50): 46751 - 46758.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2000 by the American Association of Cancer Research.